<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Genomics</journal-id><journal-id journal-id-type="publisher-id">CG</journal-id><journal-title>Current Genomics</journal-title><issn pub-type="ppub">1389-2029</issn><issn pub-type="epub">1875-5488</issn><publisher><publisher-name>Bentham Science Publishers Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19412419</article-id><article-id pub-id-type="pmc">2647155</article-id><article-id pub-id-type="publisher-id">CG-8-476</article-id><article-id pub-id-type="doi">10.2174/138920207783591681</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Incomplete Coverage of Candidate Genes: A Poorly Considered Bias</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Drago</surname><given-names>Antonio</given-names></name></contrib><contrib contrib-type="author"><name><surname>De Ronchi</surname><given-names>Diana</given-names></name></contrib><contrib contrib-type="author"><name><surname>Serretti</surname><given-names>Alessandro</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff">Institute of Psychiatry, University of Bologna, Italy</aff><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at the Institute of Psychiatry, University of Bologna, Viale Carlo Pepoli 5, 40123 Bologna, Italy; Tel: +39 051 6584233; Fax: +39 051 521030; E-mail: <email xlink:href="alessandro.serretti@unibo.it">alessandro.serretti@unibo.it</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2007</year></pub-date><volume>8</volume><issue>7</issue><fpage>476</fpage><lpage>483</lpage><history><date date-type="received"><day>29</day><month>9</month><year>2007</year></date><date date-type="rev-recd"><day>22</day><month>10</month><year>2007</year></date><date date-type="accepted"><day>1</day><month>11</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9;2007 Bentham Science Publishers Ltd.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/2.5/">http://creativecommons.org/licenses/by/2.5/</uri>) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>Current genetic investigations are performed both on the basis of a rational and biologically based choice of candidate genes and through genome wide scans. Nonetheless, lack of replication is a common problem in psychiatric genetics as well as in other genetic fields. There are a number of reasons for this inconsistency, among them a well known but poorly considered issue is gene coverage. The aim of the present paper is to focus on this well known and defectively deemed bias, especially when a candidate gene approach is chosen. The rational and the technical feasibility of this proposal are discussed as well as a survey of current investigations. The known consistent methodology to fix this bias is also discussed.</p></abstract><kwd-group><title>Key Words</title><kwd>Candidate genes</kwd><kwd>association studies</kwd><kwd>psychiatry genetics</kwd><kwd>methodology.</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>By identifying heritable risk factors, genetic association studies will reasonably help to clarify the biological basis of psychiatric disorders, to identify the most consistent prognostic factors, to simplify the therapeutic choices in every day clinic management. Anyway, despite a worldwide impressive scientific effort, there are not many conclusive results so far. This lack of consistency may be due to some methodological bias. There are roughly two main ways to investigate the associations between genetic variants and phenotypes or endophenotypes: genome wide analysis and candidate gene analysis. Going genome wide is probably the way of the future, provided that the haplotype strategy turns out to be really applicable and effective across the genome [<xref ref-type="bibr" rid="R1">1</xref>]: however, genome wide investigations focused on psychiatric disorders reported no definitive association results so far [<xref ref-type="bibr" rid="R2">2</xref>]. On the other hand, the candidate gene approach showed some good results and some genetic variations proved to be highly informative: for example, the insertion/deletion polymorphism in the promoter of the serotonin transporter has been independently demonstrated to be associated with some aspects of psychiatric disorders [<xref ref-type="bibr" rid="R3">3</xref>-<xref ref-type="bibr" rid="R5">5</xref>], and some clinical guidelines for the use of pharmacogenetic testing for CYP4502D6 and 2C19 mutations are available already [<xref ref-type="bibr" rid="R6">6</xref>]. The genome wide and candidate methods are not thought to be competitive: inductive and deductive information can be drawn with mutual advantage. Anyway, a large part of genetic research, both with genome wide and candidate gene methodologies, leaded to poorly replicated results. This might be due to a list of reasons, and some of them are methodological by nature: biases related to phenotype definitions (diagnosis, symptom clusters), sample size, selection bias, treatment lack of homogeneity, statistical biases and the little impact of a single gene over clinical phenotypes [<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8"> 8</xref>]. Beyond this well documented complexity, one well known but poorly considered bias is the incomplete coverage of genetic variations running within the gene which is under investigation. The aim of this paper is to consider if recent literature under estimated this last point. The reader will find a list of web resources helping to fix this bias at the end of the paper.</p></sec><sec><title>THE ROLE OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPs)</title><p>Since the finding of the first physical map of the human genome in 1956, the suggestion of random DNA markers to build a sequence map in 1980 [<xref ref-type="bibr" rid="R9">9</xref>], the completion of the sequence of human genome in 2003 and the first study with a genome wide technique (more than 44 clinical trials published in the last two years), the research community has now the possibility to do both wide (entire genome) and hypothesis related (single nucleotide polymorphism) genetic association studies. Briefly, DNA variations can occur at different levels: duplications, insertions, deletions and transpositions. The most frequent changes involve single nucleotide substitutions, insertions and deletions. There are two basic classes of polymorphisms: SNP (single nucleotide polymorphism) and VNTR (variable number of tandem repeats). A list of SNPs is available from public databases (<uri xlink:type="simple" xlink:href="http://www.hapmap.org/downloads/index.html.en">http://www.hapmap.org/downloads/index.html.en</uri>), and a part of these variations has a relevant prevalence within the general population: they are considered as &#x0201c;common&#x0201d; above the 5% frequency [<xref ref-type="bibr" rid="R10">10</xref>]. There is a variable number of SNPs for each gene: the longer the gene, the higher the number of running variations within its sequence. It is not easy to define the average number of one gene mutations, but it may be reasonably said that one single mutation is not representative of a gene&#x02019;s complete sequence. In fact, there might be other mutations within the same gene counteracting or enhancing the effect of the first one. We hypothesized that this simple, self &#x02013; established statement is poorly considered by recent literature. To test this hypothesis, we surveyed the literature based on genetic association studies, inclusion criteria is listed below. A special attention might be paid to one of them: a sample size threshold (about one hundred patients) was chosen as inclusion criteria. This was meant to be closer to rational concerns about the studies&#x02019; economic burden than to statistics: budget represents a relevant part in every study design, and a cut off of one hundred patients may identify studies which could afford a complete genetic analysis. Some words should be spent about this controversial topic. The definition of a statistically correct sample size for an association study appears to be quite a complex task: small sample sizes are not representative, while bigger sample sizes are associated with the risk of higher false positive rates, as recently demonstrated by Sullivan [<xref ref-type="bibr" rid="R11">11</xref>]: his <italic>in silico</italic> investigation showed dramatic rates of false positive results with a sample of 500 cases and 500 controls, examined for a set of 10 SNPs. Conflicting with this, genome wide analysis performed on thousands of patients only reported mild significant results: the recent genome wide investigation by Fanous and colleagues [<xref ref-type="bibr" rid="R12">12</xref>] (n=1383), for example, shed some light on the boundaries between schizophrenia and schizotypy, but the level of significance (p=0.04 and p=0.02) does not allow to discard the possibility of a first type error occurrence. Similar considerations might then be done for other interesting recent findings: in an relevant paper by Bulayeva and colleagues, the genome wide investigation of a set of genetic isolated schizophrenic pedigrees revealed different pattern of association with psychiatric phenotypes between younger and older pedigrees [<xref ref-type="bibr" rid="R13">13</xref>]. The study of genetic isolated pedigrees lowered the occurrence of population stratification factors, and the wide investigated sample sizes (hundreds) were a relevant point of the study, but the level of significance that was reported (p &#x0003c; 0.05) may not be considered sufficiently protective. Furthermore, it must be noticed that, even with a higher level of significance (p&#x0003c;0.002) at the genome-wide analysis, the subsequent SNP investigation does not necessarily confirm the results [<xref ref-type="bibr" rid="R14">14</xref>]. Many factors probably influenced the statistical power of these studies and therefore, they all should be considered for statistically determined correct sample size: the haplotype Linkage Disequilibrium (LD) which varies along chromosomes and within genes, the assumed genetic path associated with disorders (additive or multiplicative), the prevalence of the investigated disorder in the general population, the prevalence of the alleles associated with the disorder, and the definition of the relative risk for the disorder may represent some examples of these interactions as far as they are all influent toward the definition of a sample size tailored to a fixed statistical detection power [<xref ref-type="bibr" rid="R15">15</xref>].</p><p>So, even in the simplest case, when a candidate gene approach is chosen, the index sample size will vary according to the disorder, to the haplotype Linkage Disequilibrium average value in the candidate gene, to the associated expected Odds Ratio and so on. Thus, the correct identification of the exact average sample size for a rational analysis appears to be quite a complex task, and it is anyway beyond the aim of this paper. If the reader is interested in this topic, De La Vega recently proposed an online free software meant to deal with these issues [<xref ref-type="bibr" rid="R15">15</xref>], and the recently published HAPMAP project phase II focuses on these topics in deep too [<xref ref-type="bibr" rid="R10">10</xref>], reader&#x02019;s attention is then readdressed to these relevant publications. More simply, we choose to use the sample size to select appropriate studies for our survey on the basis that, given the economical effort leading to the selection of about two hundred persons (cases and controls), it would be worth performing a completer SNP selection, avoiding the simple bias of an incomplete investigation, which otherwise would detract from the scientific and economical effort of the study. According to this advice, we listed some recent association studies published in the last three years (July 2004 &#x02013; July 2007) in the field of psychiatric genetic research, and pointed out the investigated/known genetic variations ratio for each gene in the studies. Pubmed database was used with the following criteria:</p><list list-type="order"><list-item><p>Key words: gene, polymorphism, schizophrenic, bipolar, depressive, anxiety, obsessive, panic, PTSD, phobic.</p></list-item><list-item><p>Sample size = 90-100</p></list-item><list-item><p>Limits: Humans, Clinical Trial, Meta-Analysis, English.</p></list-item></list><p>Results are presented in Table <bold><xref ref-type="table" rid="T1">1</xref></bold>, SNP data are collected from NCBI database (<uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</uri>).</p><p>Table <bold><xref ref-type="table" rid="T1">1</xref></bold> reports the low investigated/known genetic variation ratio in almost all considered studies: the complete SNP coverage of investigated gene then represents quite a new topic in nowadays literature [<xref ref-type="bibr" rid="R16">16</xref>]. There are good and well known reasons to revalue this point: first of all, it is rational to assume that every SNP occurring in the genetic coding sequence is crucial as far as it can be associated with a change in the secondary mRNA structure: that is why silent substitutions cannot be considered <italic>a priori</italic> as devoid of interest if they run in exons. Moreover, SNPs within the coding sequence can be associated with different aminoacid sequence, leading to secondary, tertiary or quaternary possibly different protein structures, and, as a consequence or independently from it, altered function. Not all the DNA sequence is expressed in every cell [<xref ref-type="bibr" rid="R17">17</xref>], but a part of it being silent or playing a regulatory role, probably influencing the differentiation and specialisation processes [<xref ref-type="bibr" rid="R18">18</xref>-<xref ref-type="bibr" rid="R20">20</xref>]: it might be expected then that a number of SNPs will occur in non coding DNA, and may be in - or close to - a promoter, enhancer, silencer or other regulating sequence. Promoters are usually close to exons sequence (TATA box usually locate at -25bp; CAAT box at -80bp; CG box up to -950bp), but enhancers and silencers can be located at a considerable distance from the coding stream or inside introns. Other reasons to consider intronic polymorphisms relevant to genetic investigations, arise from the DNA accessibility to RNA polymerases: it is commonly accepted that this mechanism is at least partially limited by methylation and acetylation [<xref ref-type="bibr" rid="R21">21</xref>-<xref ref-type="bibr" rid="R26">26</xref>], and since cytosine has been proposed to be a site of methylation, its variation due to a change in the genetic sequence could have an influence on the gene expression. Consistently, there is evidence that the T102C silent variation influence HTR2A gene expression [<xref ref-type="bibr" rid="R27">27</xref>] probably through this mechanism. Finally, an intron variation could be completely silent but in strong Linkage Disequilibrium with a not yet known variation, possibly involving genes or sequences still far to be hypothesized as relevant to the topic of the study.</p><p>As Table <bold><xref ref-type="table" rid="T2">2</xref></bold> shows, nowadays investigations of non exon variations are limited to sequences located 1 kbp around exons. For the above mentioned considerations, scans should be wider. To complete Table <bold><xref ref-type="table" rid="T2">2</xref></bold> we used temporal criteria (the last two years), and the following key words: intron, intronic, depressive, psychotic, schizophrenic, bipolar, personality, suicide, temperament, eating, anxiety, panic, obsessive, polymorphism, SNP. Pubmed served as database. As regard to SNPs, only studies with possible identification of genetic location are included. One study for each investigated variation is included.</p><p>Finally, 3&#x02019; and 5&#x02019; endings are also important regulatory regions, and it is reasonable to assume that modifications running in these genetic sequences, or sufficiently close to, might play a relevant role. </p><p>Some lines of evidence encourage a complete analysis of single genes&#x02019; variations: Myer and colleagues recently found no significant difference in the promoter activity of HTR2A gene between the A- and G- allele of the -1438 locus when expressed with the major alleles at &#x02013;1420 C/T and &#x02013;783 A/G loci [<xref ref-type="bibr" rid="R28">28</xref>]. This was not consistent with some previous literature findings [<xref ref-type="bibr" rid="R29">29</xref>]; but when the minor allele G at -783 was found to be expressed with G-allele at -1438, the promoter activity was found to be significantly decreased. Consistently, a triallelic variant of the well known serotonin promoter polymorphism has been recently reported [<xref ref-type="bibr" rid="R30">30</xref>], and only the A allele carriers at the A/G SNP within 5-HTTLPR insertion polymorphism yield high mRNA levels, and the L(G) carriers actually behave like the low expressing short allele. This finding can explain some of the not replicated findings in literature. Moreover, previous studies which investigated only the long/short polymorphism should be reconsidered.</p><p>SNPs occur, on average, about less than 1.000 bases. Since there are about 3 billion chemical base pairs that make up human DNA and its 20.000 &#x02013; 25.000 genes, about 3 - 5 million of SNPs might be expected. This is consistent with the recent phase II Hap Map project findings [<xref ref-type="bibr" rid="R10">10</xref>]. The analysis of such a number of variations is feasible from a long time: actual techniques (Illumina and Affymetrix) permit the analysis of 500,000 or more SNPs in a single test with accessible costs, and lists of TagSNPs which can cover the complete gene sequence are easily retrievable from public databases (<uri xlink:type="simple" xlink:href="http://www.hapmap.org/downloads/index.html.en">http://www.hapmap.org/downloads/index.html.en</uri>) (<uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=9606">http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=9606</uri>). </p><p>Moreover, online free software is available which identify is a list of significant SNPs to cover a gene&#x02019;s common variations (<uri xlink:type="simple" xlink:href="http://www.broad.mit.edu/mpg/haploview/down-load.php">http://www.broad.mit.edu/mpg/haploview/down-load.php</uri>) (<uri xlink:type="simple" xlink:href="(http://marketing.appliedbiosystems.com/mk/get/SNPB_LANDING?_A=22924&#x00026;_D=18392&#x00026;_V=0">(http://marketing.appliedbiosystems.com/mk/get/SNPB_LANDING?_A=22924&#x00026;_D=18392&#x00026;_V=0).</uri>).</p><p>As a conclusion, a more complete analysis of genes&#x02019; variations does not represent a novelty in actual knowledge, and its rationality as a methodological strategy is expected to be self &#x02013; established. Nonetheless, we report here that it is a poorly considered methodological point which could be easily fixed using free internet resources and laboratory extra work, likely affordable in studies able to perform genetic and clinic assessments of hundreds of patients. There is some evidence that every day genetic clinic use will be a cost effective or even cost-saving approach in general clinical practice [<xref ref-type="bibr" rid="R31">31</xref>]: in order to hasten this process, a complete coverage of single gene polymorphisms is probably needed.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Licinio</surname><given-names>J.</given-names></name><name><surname>Wong</surname><given-names>M.L</given-names></name></person-group><article-title>Pharmacogenomics in psychiatry: genomic considerations</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>713</fpage><pub-id pub-id-type="pmid">16044177</pub-id></citation></ref><ref id="R2"><label>2</label><citation citation-type="journal"><article-title>Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>661</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">17554300</pub-id></citation></ref><ref id="R3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>H.J.</given-names></name><name><surname>Meira-Lima</surname><given-names>I.</given-names></name><name><surname>Cordeiro</surname><given-names>Q.</given-names></name><name><surname>Michelon</surname><given-names>L.</given-names></name><name><surname>Sham</surname><given-names>P.</given-names></name><name><surname>Vallada</surname><given-names>H.</given-names></name><name><surname>Collier</surname><given-names>D.A</given-names></name></person-group><article-title>Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>771</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">15824745</pub-id></citation></ref><ref id="R4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>S.</given-names></name><name><surname>Burmeister</surname><given-names>M.</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name></person-group><article-title>Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits</article-title><source>Am. J. Med. Genet</source><year>2004</year><volume>127B</volume><fpage>90</fpage><lpage>3</lpage></citation></ref><ref id="R5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Mandelli</surname><given-names>L.</given-names></name><name><surname>Lorenzi</surname><given-names>C.</given-names></name><name><surname>Pirovano</surname><given-names>A.</given-names></name><name><surname>Olgiati</surname><given-names>P.</given-names></name><name><surname>Colombo</surname><given-names>C.</given-names></name><name><surname>Smeraldi</surname><given-names>E</given-names></name></person-group><article-title>Serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders</article-title><source>Psychiatry Res</source><year>2007</year><volume>149</volume><fpage>185</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">17157919</pub-id></citation></ref><ref id="R6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Leon</surname><given-names>J.</given-names></name><name><surname>Armstrong</surname><given-names>S.C.</given-names></name><name><surname>Cozza</surname><given-names>K.L</given-names></name></person-group><article-title>Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19</article-title><source>Psychosomatics</source><year>2006</year><volume>47</volume><fpage>75</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">16384813</pub-id></citation></ref><ref id="R7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haslam</surname><given-names>N</given-names></name></person-group><article-title>Bias in psychopathology research</article-title><source>Curr. Opin. Psychiatry</source><year>2006</year><volume>19</volume><fpage>625</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">17012943</pub-id></citation></ref><ref id="R8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Kennedy</surname><given-names>J.L</given-names></name></person-group><article-title>Pharmacogenetic studies in depression: a proposal for methodologic guidelines</article-title><source>Pharmacogenomics J</source><year>2007</year></citation></ref><ref id="R9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shortle</surname><given-names>D.</given-names></name><name><surname>Koshland</surname><given-names>D.</given-names></name><name><surname>Weinstock</surname><given-names>G.M.</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name></person-group><article-title>Segment-directed mutagenesis: construction <italic>in vitro</italic> of point mutations limited to a small predetermined region of a circular DNA molecule</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1980</year><volume>77</volume><fpage>5375</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">6254078</pub-id></citation></ref><ref id="R10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frazer</surname><given-names>K.A.</given-names></name><name><surname>Ballinger</surname><given-names>D.G.</given-names></name><name><surname>Cox</surname><given-names>D.R.</given-names></name><name><surname>Hinds</surname><given-names>D.A.</given-names></name><name><surname>Stuve</surname><given-names>L.L.</given-names></name><name><surname>Gibbs</surname><given-names>R.A.</given-names></name><name><surname>Belmont</surname><given-names>J.W.</given-names></name><name><surname>Boudreau</surname><given-names>A.</given-names></name><name><surname>Hardenbol</surname><given-names>P.</given-names></name><name><surname>Leal</surname><given-names>S.M.</given-names></name><name><surname>Pasternak</surname><given-names>S.</given-names></name><name><surname>Wheeler</surname><given-names>D.A.</given-names></name><name><surname>Willis</surname><given-names>T.D.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Gabriel</surname><given-names>S.B.</given-names></name><name><surname>Barry</surname><given-names>R.</given-names></name><name><surname>Blumenstiel</surname><given-names>B.</given-names></name><name><surname>Camargo</surname><given-names>A.</given-names></name><name><surname>Defelice</surname><given-names>M.</given-names></name><name><surname>Faggart</surname><given-names>M.</given-names></name><name><surname>Goyette</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Moore</surname><given-names>J.</given-names></name><name><surname>Nguyen</surname><given-names>H.</given-names></name><name><surname>Onofrio</surname><given-names>R.C.</given-names></name><name><surname>Parkin</surname><given-names>M.</given-names></name><name><surname>Roy</surname><given-names>J.</given-names></name><name><surname>Stahl</surname><given-names>E.</given-names></name><name><surname>Winchester</surname><given-names>E.</given-names></name><name><surname>Ziaugra</surname><given-names>L.</given-names></name><name><surname>Altshuler</surname><given-names>D.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Chu</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xiong</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Waye</surname><given-names>M.M.</given-names></name><name><surname>Tsui</surname><given-names>S.K.</given-names></name><name><surname>Xue</surname><given-names>H.</given-names></name><name><surname>Wong</surname><given-names>J.T.</given-names></name><name><surname>Galver</surname><given-names>L.M.</given-names></name><name><surname>Fan</surname><given-names>J.B.</given-names></name><name><surname>Gunderson</surname><given-names>K.</given-names></name><name><surname>Murray</surname><given-names>S.S.</given-names></name><name><surname>Oliphant</surname><given-names>A.R.</given-names></name><name><surname>Chee</surname><given-names>M.S.</given-names></name><name><surname>Montpetit</surname><given-names>A.</given-names></name><name><surname>Chagnon</surname><given-names>F.</given-names></name><name><surname>Ferretti</surname><given-names>V.</given-names></name><name><surname>Leboeuf</surname><given-names>M.</given-names></name><name><surname>Olivier</surname><given-names>J.F.</given-names></name><name><surname>Phillips</surname><given-names>M.S.</given-names></name><name><surname>Roumy</surname><given-names>S.</given-names></name><name><surname>Sall&#x000e9;e</surname><given-names>C.</given-names></name><name><surname>Verner</surname><given-names>A.</given-names></name><name><surname>Hudson</surname><given-names>T.J.</given-names></name><name><surname>Kwok</surname><given-names>P.Y.</given-names></name><name><surname>Cai</surname><given-names>D.</given-names></name><name><surname>Koboldt</surname><given-names>D.C.</given-names></name><name><surname>Miller</surname><given-names>R.D.</given-names></name><name><surname>Pawlikowska</surname><given-names>L.</given-names></name><name><surname>Taillon-Miller</surname><given-names>P.</given-names></name><name><surname>Xiao</surname><given-names>M.</given-names></name><name><surname>Tsui</surname><given-names>L.C.</given-names></name><name><surname>Mak</surname><given-names>W.</given-names></name><name><surname>Song</surname><given-names>Y.Q.</given-names></name><name><surname>Tam</surname><given-names>P.K.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Kawaguchi</surname><given-names>T.</given-names></name><name><surname>Kitamoto</surname><given-names>T.</given-names></name><name><surname>Morizono</surname><given-names>T.</given-names></name><name><surname>Nagashima</surname><given-names>A.</given-names></name><name><surname>Ohnishi</surname><given-names>Y.</given-names></name><name><surname>Sekine</surname><given-names>A.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Tsunoda</surname><given-names>T.</given-names></name><name><surname>Deloukas</surname><given-names>P.</given-names></name><name><surname>Bird</surname><given-names>C.P.</given-names></name><name><surname>Delgado</surname><given-names>M.</given-names></name><name><surname>Dermitzakis</surname><given-names>E.T.</given-names></name><name><surname>Gwilliam</surname><given-names>R.</given-names></name><name><surname>Hunt</surname><given-names>S.</given-names></name><name><surname>Morrison</surname><given-names>J.</given-names></name><name><surname>Powell</surname><given-names>D.</given-names></name><name><surname>Stranger</surname><given-names>B.E.</given-names></name><name><surname>Whittaker</surname><given-names>P.</given-names></name><name><surname>Bentley</surname><given-names>D.R.</given-names></name><name><surname>Daly</surname><given-names>M.J.</given-names></name><name><surname>de Bakker</surname><given-names>P.I.</given-names></name><name><surname>Barrett</surname><given-names>J.</given-names></name><name><surname>Chretien</surname><given-names>Y.R.</given-names></name><name><surname>Maller</surname><given-names>J.</given-names></name><name><surname>McCarroll</surname><given-names>S.</given-names></name><name><surname>Patterson</surname><given-names>N.</given-names></name><name><surname>Pe'er</surname><given-names>I.</given-names></name><name><surname>Price</surname><given-names>A.</given-names></name><name><surname>Purcell</surname><given-names>S.</given-names></name><name><surname>Richter</surname><given-names>D.J.</given-names></name><name><surname>Sabeti</surname><given-names>P.</given-names></name><name><surname>Saxena</surname><given-names>R.</given-names></name><name><surname>Schaffner</surname><given-names>S.F.</given-names></name><name><surname>Sham</surname><given-names>P.C.</given-names></name><name><surname>Varilly</surname><given-names>P.</given-names></name><name><surname>Altshuler</surname><given-names>D.</given-names></name><name><surname>Stein</surname><given-names>L.D.</given-names></name><name><surname>Krishnan</surname><given-names>L.</given-names></name><name><surname>Smith</surname><given-names>A.V.</given-names></name><name><surname>Tello-Ruiz</surname><given-names>M.K.</given-names></name><name><surname>Thorisson</surname><given-names>G.A.</given-names></name><name><surname>Chakravarti</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>P.E.</given-names></name><name><surname>Cutler</surname><given-names>D.J.</given-names></name><name><surname>Kashuk</surname><given-names>C.S.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Abecasis</surname><given-names>G.R.</given-names></name><name><surname>Guan</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Munro</surname><given-names>H.M.</given-names></name><name><surname>Qin</surname><given-names>Z.S.</given-names></name><name><surname>Thomas</surname><given-names>D.J.</given-names></name><name><surname>McVean</surname><given-names>G.</given-names></name><name><surname>Auton</surname><given-names>A.</given-names></name><name><surname>Bottolo</surname><given-names>L.</given-names></name><name><surname>Cardin</surname><given-names>N.</given-names></name><name><surname>Eyheramendy</surname><given-names>S.</given-names></name><name><surname>Freeman</surname><given-names>C.</given-names></name><name><surname>Marchini</surname><given-names>J.</given-names></name><name><surname>Myers</surname><given-names>S.</given-names></name><name><surname>Spencer</surname><given-names>C.</given-names></name><name><surname>Stephens</surname><given-names>M.</given-names></name><name><surname>Donnelly</surname><given-names>P.</given-names></name><name><surname>Cardon</surname><given-names>L.R.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Evans</surname><given-names>D.M.</given-names></name><name><surname>Morris</surname><given-names>A.P.</given-names></name><name><surname>Weir</surname><given-names>B.S.</given-names></name><name><surname>Tsunoda</surname><given-names>T.</given-names></name><name><surname>Mullikin</surname><given-names>J.C.</given-names></name><name><surname>Sherry</surname><given-names>S.T.</given-names></name><name><surname>Feolo</surname><given-names>M.</given-names></name><name><surname>Skol</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Matsuda</surname><given-names>I.</given-names></name><name><surname>Fukushima</surname><given-names>Y.</given-names></name><name><surname>Macer</surname><given-names>D.R.</given-names></name><name><surname>Suda</surname><given-names>E.</given-names></name><name><surname>Rotimi</surname><given-names>C.N.</given-names></name><name><surname>Adebamowo</surname><given-names>C.A.</given-names></name><name><surname>Ajayi</surname><given-names>I.</given-names></name><name><surname>Aniagwu</surname><given-names>T.</given-names></name><name><surname>Marshall</surname><given-names>P.A.</given-names></name><name><surname>Nkwodimmah</surname><given-names>C.</given-names></name><name><surname>Royal</surname><given-names>C.D.</given-names></name><name><surname>Leppert</surname><given-names>M.F.</given-names></name><name><surname>Dixon</surname><given-names>M.</given-names></name><name><surname>Peiffer</surname><given-names>A.</given-names></name><name><surname>Qiu</surname><given-names>R.</given-names></name><name><surname>Kent</surname><given-names>A.</given-names></name><name><surname>Kato</surname><given-names>K.</given-names></name><name><surname>Niikawa</surname><given-names>N.</given-names></name><name><surname>Adewole</surname><given-names>I.F.</given-names></name><name><surname>Knoppers</surname><given-names>B.M.</given-names></name><name><surname>Foster</surname><given-names>M.W.</given-names></name><name><surname>Clayton</surname><given-names>E.W.</given-names></name><name><surname>Watkin</surname><given-names>J.</given-names></name><name><surname>Gibbs</surname><given-names>R.A.</given-names></name><name><surname>Belmont</surname><given-names>J.W.</given-names></name><name><surname>Muzny</surname><given-names>D.</given-names></name><name><surname>Nazareth</surname><given-names>L.</given-names></name><name><surname>Sodergren</surname><given-names>E.</given-names></name><name><surname>Weinstock</surname><given-names>G.M.</given-names></name><name><surname>Wheeler</surname><given-names>D.A.</given-names></name><name><surname>Yakub</surname><given-names>I.</given-names></name><name><surname>Gabriel</surname><given-names>S.B.</given-names></name><name><surname>Onofrio</surname><given-names>R.C.</given-names></name><name><surname>Richter</surname><given-names>D.J.</given-names></name><name><surname>Ziaugra</surname><given-names>L.</given-names></name><name><surname>Birren</surname><given-names>B.W.</given-names></name><name><surname>Daly</surname><given-names>M.J.</given-names></name><name><surname>Altshuler</surname><given-names>D.</given-names></name><name><surname>Wilson</surname><given-names>R.K.</given-names></name><name><surname>Fulton</surname><given-names>L.L.</given-names></name><name><surname>Rogers</surname><given-names>J.</given-names></name><name><surname>Burton</surname><given-names>J.</given-names></name><name><surname>Carter</surname><given-names>N.P.</given-names></name><name><surname>Clee</surname><given-names>C.M.</given-names></name><name><surname>Griffiths</surname><given-names>M.</given-names></name><name><surname>Jones</surname><given-names>M.C.</given-names></name><name><surname>McLay</surname><given-names>K.</given-names></name><name><surname>Plumb</surname><given-names>R.W.</given-names></name><name><surname>Ross</surname><given-names>M.T.</given-names></name><name><surname>Sims</surname><given-names>S.K.</given-names></name><name><surname>Willey</surname><given-names>D.L.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>H.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Godbout</surname><given-names>M.</given-names></name><name><surname>Wallenburg</surname><given-names>J.C.</given-names></name><name><surname>L'Archev&#x000ea;que</surname><given-names>P.</given-names></name><name><surname>Bellemare</surname><given-names>G.</given-names></name><name><surname>Saeki</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>An</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Holden</surname><given-names>A.L.</given-names></name><name><surname>Brooks</surname><given-names>L.D.</given-names></name><name><surname>McEwen</surname><given-names>J.E.</given-names></name><name><surname>Guyer</surname><given-names>M.S.</given-names></name><name><surname>Wang</surname><given-names>V.O.</given-names></name><name><surname>Peterson</surname><given-names>J.L.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Spiegel</surname><given-names>J.</given-names></name><name><surname>Sung</surname><given-names>L.M.</given-names></name><name><surname>Zacharia</surname><given-names>L.F.</given-names></name><name><surname>Collins</surname><given-names>F.S.</given-names></name><name><surname>Kennedy</surname><given-names>K.</given-names></name><name><surname>Jamieson</surname><given-names>R.</given-names></name><name><surname>Stewart</surname><given-names>J.A</given-names></name></person-group><article-title>second generation human haplotype map of over 3.1 million SNPs</article-title><source>Nature</source><year>2007</year><volume>449</volume><fpage>851</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17943122</pub-id></citation></ref><ref id="R11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>P.F</given-names></name></person-group><article-title>Spurious genetic associations</article-title><source>Biol. Psychiatry</source><year>2007</year><volume>61</volume><fpage>1121</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17346679</pub-id></citation></ref><ref id="R12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fanous</surname><given-names>A.H.</given-names></name><name><surname>Neale</surname><given-names>M.C.</given-names></name><name><surname>Gardner</surname><given-names>C.O.</given-names></name><name><surname>Webb</surname><given-names>B.T.</given-names></name><name><surname>Straub</surname><given-names>R.E.</given-names></name><name><surname>O'Neill</surname><given-names>F.A.</given-names></name><name><surname>Walsh</surname><given-names>D.</given-names></name><name><surname>Riley</surname><given-names>B.P.</given-names></name><name><surname>Kendler</surname><given-names>K.S</given-names></name></person-group><article-title>Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>958</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">17440434</pub-id></citation></ref><ref id="R13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulayeva</surname><given-names>K.B.</given-names></name><name><surname>Glatt</surname><given-names>S.J.</given-names></name><name><surname>Bulayev</surname><given-names>O.A.</given-names></name><name><surname>Pavlova</surname><given-names>T.A.</given-names></name><name><surname>Tsuang</surname><given-names>M.T</given-names></name></person-group><article-title>Genome-wide linkage scan of schizophrenia: a cross-isolate study</article-title><source>Genomics</source><year>2007</year><volume>89</volume><fpage>167</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">17140763</pub-id></citation></ref><ref id="R14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vazza</surname><given-names>G.</given-names></name><name><surname>Bertolin</surname><given-names>C.</given-names></name><name><surname>Scudellaro</surname><given-names>E.</given-names></name><name><surname>Vettori</surname><given-names>A.</given-names></name><name><surname>Boaretto</surname><given-names>F.</given-names></name><name><surname>Rampinelli</surname><given-names>S.</given-names></name><name><surname>De Sanctis</surname><given-names>G.</given-names></name><name><surname>Perini</surname><given-names>G.</given-names></name><name><surname>Peruzzi</surname><given-names>P.</given-names></name><name><surname>Mostacciuolo</surname><given-names>M.L</given-names></name></person-group><article-title>Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16969366</pub-id></citation></ref><ref id="R15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De La Vega</surname><given-names>F.M</given-names></name></person-group><article-title>Selecting single-nucleotide polymorphisms for association studies with SNPbrowser software</article-title><source>Methods Mol. Biol</source><year>2007</year><volume>376</volume><fpage>177</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">17984546</pub-id></citation></ref><ref id="R16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horne</surname><given-names>B.D.</given-names></name><name><surname>Camp</surname><given-names>N.J</given-names></name></person-group><article-title>Principal component analysis for selection of optimal SNP-sets that capture intragenic genetic variation</article-title><source>Genet. Epidemiol</source><year>2004</year><volume>26</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">14691953</pub-id></citation></ref><ref id="R17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schena</surname><given-names>M.</given-names></name><name><surname>Heller</surname><given-names>R.A.</given-names></name><name><surname>Theriault</surname><given-names>T.P.</given-names></name><name><surname>Konrad</surname><given-names>K.</given-names></name><name><surname>Lachenmeier</surname><given-names>E.</given-names></name><name><surname>Davis</surname><given-names>R.W</given-names></name></person-group><article-title>Microarrays: biotechnology's discovery platform for functional genomics</article-title><source>Trends Biotechnol</source><year>1998</year><volume>16</volume><fpage>301</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9675914</pub-id></citation></ref><ref id="R18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halbleib</surname><given-names>J.M.</given-names></name><name><surname>Saaf</surname><given-names>A.M.</given-names></name><name><surname>Brown</surname><given-names>P.O.</given-names></name><name><surname>Nelson</surname><given-names>W.J</given-names></name></person-group><article-title>Transcriptional modulation of genes encoding structural characteristics of differentiating enterocytes during development of a polarized epithelium <italic>in vitro</italic></article-title><source>Mol. Biol. Cell</source><year>2007</year><volume>18</volume><fpage>4261</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">17699590</pub-id></citation></ref><ref id="R19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milanesi</surname><given-names>L.</given-names></name><name><surname>Petrillo</surname><given-names>M.</given-names></name><name><surname>Sepe</surname><given-names>L.</given-names></name><name><surname>Boccia</surname><given-names>A.</given-names></name><name><surname>D'Agostino</surname><given-names>N.</given-names></name><name><surname>Passamano</surname><given-names>M.</given-names></name><name><surname>Di Nardo</surname><given-names>S.</given-names></name><name><surname>Tasco</surname><given-names>G.</given-names></name><name><surname>Casadio</surname><given-names>R.</given-names></name><name><surname>Paolella</surname><given-names>G</given-names></name></person-group><article-title>Systematic analysis of human kinase genes: a large number of genes and alternative splicing events result in functional and structural diversity</article-title><source>BMC Bioinformatics</source><year>2005</year><volume>6</volume><issue>Suppl 4</issue><fpage>S20</fpage><pub-id pub-id-type="pmid">16351747</pub-id></citation></ref><ref id="R20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vinogradov</surname><given-names>A.E.</given-names></name><name><surname>Anatskaya</surname><given-names>O.V</given-names></name></person-group><article-title>Organismal complexity, cell differentiation and gene expression: human over mouse</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>6350</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17881362</pub-id></citation></ref><ref id="R21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>A.J.</given-names></name><name><surname>Miska</surname><given-names>E.A</given-names></name></person-group><article-title>Regulation of gene expression by transcription factor acetylation</article-title><source>Cell Mol. Life Sci</source><year>2000</year><volume>57</volume><fpage>1184</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11028911</pub-id></citation></ref><ref id="R22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>Y.</given-names></name><name><surname>Koga</surname><given-names>M.</given-names></name><name><surname>Arai</surname><given-names>M.</given-names></name><name><surname>Noguchi</surname><given-names>E.</given-names></name><name><surname>Ohtsuki</surname><given-names>T.</given-names></name><name><surname>Horiuchi</surname><given-names>Y.</given-names></name><name><surname>Ishiguro</surname><given-names>H.</given-names></name><name><surname>Niizato</surname><given-names>K.</given-names></name><name><surname>Iritani</surname><given-names>S.</given-names></name><name><surname>Itokawa</surname><given-names>M.</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name></person-group><article-title>Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytes</article-title><source>Biol. Psychiatry</source><year>2006</year><volume>60</volume><fpage>1331</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17069769</pub-id></citation></ref><ref id="R23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>A.R.</given-names></name><name><surname>Hu</surname><given-names>J.F</given-names></name></person-group><article-title>Directing DNA methylation to inhibit gene expression</article-title><source>Cell Mol. Neurobiol</source><year>2006</year><volume>26</volume><fpage>425</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">16710755</pub-id></citation></ref><ref id="R24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serman</surname><given-names>A.</given-names></name><name><surname>Vlahovic</surname><given-names>M.</given-names></name><name><surname>Serman</surname><given-names>L.</given-names></name><name><surname>Bulic-Jakus</surname><given-names>F</given-names></name></person-group><article-title>DNA methylation as a regulatory mechanism for gene expression in mammals</article-title><source>Coll. Antropol</source><year>2006</year><volume>30</volume><fpage>665</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17058541</pub-id></citation></ref><ref id="R25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shilatifard</surname><given-names>A</given-names></name></person-group><article-title>Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression</article-title><source>Annu. Rev. Biochem</source><year>2006</year><volume>75</volume><fpage>243</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">16756492</pub-id></citation></ref><ref id="R26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verdone</surname><given-names>L.</given-names></name><name><surname>Caserta</surname><given-names>M.</given-names></name><name><surname>Di Mauro</surname><given-names>E</given-names></name></person-group><article-title>Role of histone acetylation in the control of gene expression</article-title><source>Biochem. Cell Biol</source><year>2005</year><volume>83</volume><fpage>344</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15959560</pub-id></citation></ref><ref id="R27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clifford</surname><given-names>C.P.</given-names></name><name><surname>Nunez</surname><given-names>D.J</given-names></name></person-group><article-title>5HT 2a receptor T102C polymorphism and schizophrenia</article-title><source>Lancet</source><year>1996</year><volume>347</volume><fpage>1830</fpage><pub-id pub-id-type="pmid">8667936</pub-id></citation></ref><ref id="R28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>R.L.</given-names></name><name><surname>Airey</surname><given-names>D.C.</given-names></name><name><surname>Manier</surname><given-names>D.H.</given-names></name><name><surname>Shelton</surname><given-names>R.C.</given-names></name><name><surname>Sanders-Bush</surname><given-names>E</given-names></name></person-group><article-title>Polymorphisms in the Regulatory Region of the Human Serotonin 5-HT(2A) Receptor Gene (HTR2A) Influence Gene Expression</article-title><source>Biol. Psychiatry</source><year>2006</year><volume>11</volume></citation></ref><ref id="R29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Drago</surname><given-names>A.</given-names></name><name><surname>De Ronchi</surname><given-names>D</given-names></name></person-group><article-title>HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies</article-title><source>Curr. Med. Chem</source><year>2007</year><volume>14</volume><fpage>2053</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">17691947</pub-id></citation></ref><ref id="R30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X.Z.</given-names></name><name><surname>Rush</surname><given-names>A.J.</given-names></name><name><surname>Charney</surname><given-names>D.</given-names></name><name><surname>Wilson</surname><given-names>A.F.</given-names></name><name><surname>Sorant</surname><given-names>A.J.</given-names></name><name><surname>Papanicolaou</surname><given-names>G.J.</given-names></name><name><surname>Fava</surname><given-names>M.</given-names></name><name><surname>Trivedi</surname><given-names>M.H.</given-names></name><name><surname>Wisniewski</surname><given-names>S.R.</given-names></name><name><surname>Laje</surname><given-names>G.</given-names></name><name><surname>Paddock</surname><given-names>S.</given-names></name><name><surname>McMahon</surname><given-names>F.J.</given-names></name><name><surname>Manji</surname><given-names>H.</given-names></name><name><surname>Lipsky</surname><given-names>R.H</given-names></name></person-group><article-title>Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression</article-title><source>Arch. Gen. Psychiatry</source><year>2007</year><volume>64</volume><fpage>783</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17606812</pub-id></citation></ref><ref id="R31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rogowski</surname><given-names>W</given-names></name></person-group><article-title>Genetic screening by DNA technology: a systematic review of health economic evidence</article-title><source>Int. J. Technol. Assess Health Care</source><year>2006</year><volume>22</volume><fpage>327</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">16984061</pub-id></citation></ref><ref id="R32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perlis</surname><given-names>R.H.</given-names></name><name><surname>Purcell</surname><given-names>S.</given-names></name><name><surname>Fava</surname><given-names>M.</given-names></name><name><surname>Fagerness</surname><given-names>J.</given-names></name><name><surname>Rush</surname><given-names>A.J.</given-names></name><name><surname>Trivedi</surname><given-names>M.H.</given-names></name><name><surname>Smoller</surname><given-names>J.W</given-names></name></person-group><article-title>Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study</article-title><source>Arch. Gen. Psychiatry</source><year>2007</year><volume>64</volume><fpage>689</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">17548750</pub-id></citation></ref><ref id="R33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Mandelli</surname><given-names>L.</given-names></name><name><surname>Giegling</surname><given-names>I.</given-names></name><name><surname>Schneider</surname><given-names>B.</given-names></name><name><surname>Hartmann</surname><given-names>A.M.</given-names></name><name><surname>Schnabel</surname><given-names>A.</given-names></name><name><surname>Maurer</surname><given-names>K.</given-names></name><name><surname>Moller</surname><given-names>H.J.</given-names></name><name><surname>Rujescu</surname><given-names>D</given-names></name></person-group><article-title>HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers</article-title><source>Am. J. Med. Genet. B. Neuropsychiatr. Genet</source><year>2007</year><volume>144</volume><fpage>291</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17192951</pub-id></citation></ref><ref id="R34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dick</surname><given-names>D.M.</given-names></name><name><surname>Plunkett</surname><given-names>J.</given-names></name><name><surname>Hamlin</surname><given-names>D.</given-names></name><name><surname>Nurnberger J</surname><given-names>J.r</given-names></name><name><surname>Kuperman</surname><given-names>S.</given-names></name><name><surname>Schuckit</surname><given-names>M.</given-names></name><name><surname>Hesselbrock</surname><given-names>V.</given-names></name><name><surname>Edenberg</surname><given-names>H.</given-names></name><name><surname>Bierut</surname><given-names>L</given-names></name></person-group><article-title>Association analyses of the serotonin transporter gene with lifetime depression and alcohol dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample</article-title><source>Psychiatr. Genet</source><year>2007</year><volume>17</volume><fpage>35</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17167343</pub-id></citation></ref><ref id="R35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>De Ronchi</surname><given-names>D.</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name></person-group><article-title>Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>247</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17146470</pub-id></citation></ref><ref id="R36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kraft</surname><given-names>J.B.</given-names></name><name><surname>Peters</surname><given-names>E.J.</given-names></name><name><surname>Slager</surname><given-names>S.L.</given-names></name><name><surname>Jenkins</surname><given-names>G.D.</given-names></name><name><surname>Reinalda</surname><given-names>M.S.</given-names></name><name><surname>McGrath</surname><given-names>P.J.</given-names></name><name><surname>Hamilton</surname><given-names>S.P</given-names></name></person-group><article-title>Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample</article-title><source>Biol. Psychiatry</source><year>2007</year><volume>61</volume><fpage>734</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">17123473</pub-id></citation></ref><ref id="R37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilbody</surname><given-names>S.</given-names></name><name><surname>Lewis</surname><given-names>S.</given-names></name><name><surname>Lightfoot</surname><given-names>T</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review</article-title><source>Am. J. Epidemiol</source><year>2007</year><volume>165</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">17074966</pub-id></citation></ref><ref id="R38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">16969368</pub-id></citation></ref><ref id="R39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>P.Y</given-names></name></person-group><article-title>Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder</article-title><source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source><year>2007</year><volume>31</volume><fpage>683</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17291658</pub-id></citation></ref><ref id="R40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>P.R.</given-names></name><name><surname>McKenzie</surname><given-names>J.M.</given-names></name><name><surname>Mulder</surname><given-names>R.T.</given-names></name><name><surname>Luty</surname><given-names>S.E.</given-names></name><name><surname>Sullivan</surname><given-names>P.F.</given-names></name><name><surname>Miller</surname><given-names>A.L.</given-names></name><name><surname>Kennedy</surname><given-names>M.A</given-names></name></person-group><article-title>Genetic, developmental and personality correlates of self-mutilation in depressed patients</article-title><source>Aust. N. Z. J. Psychiatry</source><year>2006</year><volume>40</volume><fpage>225</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16476149</pub-id></citation></ref><ref id="R41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.W.</given-names></name><name><surname>Tsai</surname><given-names>S.J.</given-names></name><name><surname>Liou</surname><given-names>Y.J.</given-names></name><name><surname>Hong</surname><given-names>C.J.</given-names></name><name><surname>Chen</surname><given-names>T.J</given-names></name></person-group><article-title>Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders</article-title><source>Eur. Neuropsychopharmacol</source><year>2006</year><volume>16</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">16458487</pub-id></citation></ref><ref id="R42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Surtees</surname><given-names>P.G.</given-names></name><name><surname>Wainwright</surname><given-names>N.W.</given-names></name><name><surname>Willis-Owen</surname><given-names>S.A.</given-names></name><name><surname>Luben</surname><given-names>R.</given-names></name><name><surname>Day</surname><given-names>N.E.</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name></person-group><article-title>Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder</article-title><source>Biol. Psychiatry</source><year>2006</year><volume>59</volume><fpage>224</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16154545</pub-id></citation></ref><ref id="R43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez de Lara</surname><given-names>C.</given-names></name><name><surname>Dumais</surname><given-names>A.</given-names></name><name><surname>Rouleau</surname><given-names>G.</given-names></name><name><surname>Lesage</surname><given-names>A.</given-names></name><name><surname>Dumont</surname><given-names>M.</given-names></name><name><surname>Chawky</surname><given-names>N.</given-names></name><name><surname>Alda</surname><given-names>M.</given-names></name><name><surname>Benkelfat</surname><given-names>C.</given-names></name><name><surname>Turecki</surname><given-names>G</given-names></name></person-group><article-title>STin2 variant and family history of suicide as significant predictors of suicide completion in major depression</article-title><source>Biol. Psychiatry</source><year>2006</year><volume>59</volume><fpage>114</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16125146</pub-id></citation></ref><ref id="R44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tochigi</surname><given-names>M.</given-names></name><name><surname>Hibino</surname><given-names>H.</given-names></name><name><surname>Otowa</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>C.</given-names></name><name><surname>Marui</surname><given-names>T.</given-names></name><name><surname>Ohtani</surname><given-names>T.</given-names></name><name><surname>Umekage</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>N.</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name></person-group><article-title>Association between dopamine D4 receptor (DRD4) exon III polymorphism and Neuroticism in the Japanese population</article-title><source>Neurosci. Lett</source><year>2006</year><volume>398</volume><fpage>333</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16472910</pub-id></citation></ref><ref id="R45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Politi</surname><given-names>P.</given-names></name><name><surname>Minoretti</surname><given-names>P.</given-names></name><name><surname>Falcone</surname><given-names>C.</given-names></name><name><surname>Martinelli</surname><given-names>V.</given-names></name><name><surname>Emanuele</surname><given-names>E</given-names></name></person-group><article-title>Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder</article-title><source>Neurosci. Lett</source><year>2006</year><volume>396</volume><fpage>163</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16352396</pub-id></citation></ref><ref id="R46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belfer</surname><given-names>I.</given-names></name><name><surname>Hipp</surname><given-names>H.</given-names></name><name><surname>McKnight</surname><given-names>C.</given-names></name><name><surname>Evans</surname><given-names>C.</given-names></name><name><surname>Buzas</surname><given-names>B.</given-names></name><name><surname>Bollettino</surname><given-names>A.</given-names></name><name><surname>Albaugh</surname><given-names>B.</given-names></name><name><surname>Virkkunen</surname><given-names>M.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Max</surname><given-names>M.B.</given-names></name><name><surname>Goldman</surname><given-names>D.</given-names></name><name><surname>Enoch</surname><given-names>M.A</given-names></name></person-group><article-title>Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations</article-title><source>Mol. Psychiatry</source><year>2006</year><volume>11</volume><fpage>301</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16314872</pub-id></citation></ref><ref id="R47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fanous</surname><given-names>A.H.</given-names></name><name><surname>van den Oord</surname><given-names>E.J.</given-names></name><name><surname>Riley</surname><given-names>B.P.</given-names></name><name><surname>Aggen</surname><given-names>S.H.</given-names></name><name><surname>Neale</surname><given-names>M.C.</given-names></name><name><surname>O'Neill</surname><given-names>F.A.</given-names></name><name><surname>Walsh</surname><given-names>D.</given-names></name><name><surname>Kendler</surname><given-names>K.S</given-names></name></person-group><article-title>Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia</article-title><source>Am. J. Psychiatry</source><year>2005</year><volume>162</volume><fpage>1824</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">16199828</pub-id></citation></ref><ref id="R48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>J.</given-names></name><name><surname>Jamra</surname><given-names>R.A.</given-names></name><name><surname>Becker</surname><given-names>T.</given-names></name><name><surname>Ohlraun</surname><given-names>S.</given-names></name><name><surname>Klopp</surname><given-names>N.</given-names></name><name><surname>Binder</surname><given-names>E.B.</given-names></name><name><surname>Schulze</surname><given-names>T.G.</given-names></name><name><surname>Deschner</surname><given-names>M.</given-names></name><name><surname>Schmal</surname><given-names>C.</given-names></name><name><surname>Hofels</surname><given-names>S.</given-names></name><name><surname>Zobel</surname><given-names>A.</given-names></name><name><surname>Illig</surname><given-names>T.</given-names></name><name><surname>Propping</surname><given-names>P.</given-names></name><name><surname>Holsboer</surname><given-names>F.</given-names></name><name><surname>Rietschel</surname><given-names>M.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Cichon</surname><given-names>S</given-names></name></person-group><article-title>Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression</article-title><source>Biol. Psychiatry</source><year>2005</year><volume>58</volume><fpage>307</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">16005437</pub-id></citation></ref><ref id="R49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Cusin</surname><given-names>C.</given-names></name><name><surname>Benedetti</surname><given-names>F.</given-names></name><name><surname>Mandelli</surname><given-names>L.</given-names></name><name><surname>Pirovano</surname><given-names>A.</given-names></name><name><surname>Zanardi</surname><given-names>R.</given-names></name><name><surname>Colombo</surname><given-names>C.</given-names></name><name><surname>Smeraldi</surname><given-names>E</given-names></name></person-group><article-title>Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism</article-title><source>Am. J. Med. Genet. B. Neuropsychiatr. Genet</source><year>2005</year><volume>137</volume><fpage>36</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15952199</pub-id></citation></ref><ref id="R50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bondy</surname><given-names>B.</given-names></name><name><surname>Baghai</surname><given-names>T.C.</given-names></name><name><surname>Zill</surname><given-names>P.</given-names></name><name><surname>Schule</surname><given-names>C.</given-names></name><name><surname>Eser</surname><given-names>D.</given-names></name><name><surname>Deiml</surname><given-names>T.</given-names></name><name><surname>Zwanzger</surname><given-names>P.</given-names></name><name><surname>Ella</surname><given-names>R.</given-names></name><name><surname>Rupprecht</surname><given-names>R</given-names></name></person-group><article-title>Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression</article-title><source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source><year>2005</year><volume>29</volume><fpage>1094</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15949885</pub-id></citation></ref><ref id="R51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massat</surname><given-names>I.</given-names></name><name><surname>Souery</surname><given-names>D.</given-names></name><name><surname>Del-Favero</surname><given-names>J.</given-names></name><name><surname>Nothen</surname><given-names>M.</given-names></name><name><surname>Blackwood</surname><given-names>D.</given-names></name><name><surname>Muir</surname><given-names>W.</given-names></name><name><surname>Kaneva</surname><given-names>R.</given-names></name><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Lorenzi</surname><given-names>C.</given-names></name><name><surname>Rietschel</surname><given-names>M.</given-names></name><name><surname>Milanova</surname><given-names>V.</given-names></name><name><surname>Papadimitriou</surname><given-names>G.N.</given-names></name><name><surname>Dikeos</surname><given-names>D.</given-names></name><name><surname>Van Broekhoven</surname><given-names>C.</given-names></name><name><surname>Mendlewicz</surname><given-names>J</given-names></name></person-group><article-title>Association between COMT (Val(158)Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>598</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">15583702</pub-id></citation></ref><ref id="R52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>P.A.</given-names></name><name><surname>Wray</surname><given-names>N.R.</given-names></name><name><surname>Thomson</surname><given-names>A.M.</given-names></name><name><surname>Dunbar</surname><given-names>D.R.</given-names></name><name><surname>Grassie</surname><given-names>M.A.</given-names></name><name><surname>Condie</surname><given-names>A.</given-names></name><name><surname>Walker</surname><given-names>M.T.</given-names></name><name><surname>Smith</surname><given-names>D.J.</given-names></name><name><surname>Pulford</surname><given-names>D.J.</given-names></name><name><surname>Muir</surname><given-names>W.</given-names></name><name><surname>Blackwood</surname><given-names>D.H.</given-names></name><name><surname>Porteous</surname><given-names>D.J</given-names></name></person-group><article-title>Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>470</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15452587</pub-id></citation></ref><ref id="R53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grabe</surname><given-names>H.J.</given-names></name><name><surname>Lange</surname><given-names>M.</given-names></name><name><surname>Wolff</surname><given-names>B.</given-names></name><name><surname>Volzke</surname><given-names>H.</given-names></name><name><surname>Lucht</surname><given-names>M.</given-names></name><name><surname>Freyberger</surname><given-names>H.J.</given-names></name><name><surname>John</surname><given-names>U.</given-names></name><name><surname>Cascorbi</surname><given-names>I</given-names></name></person-group><article-title>Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>220</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15263905</pub-id></citation></ref><ref id="R54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.J.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>C.H</given-names></name></person-group><article-title>Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism</article-title><source>Neuropsychobiology</source><year>2005</year><volume>52</volume><fpage>176</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">16220023</pub-id></citation></ref><ref id="R55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zai</surname><given-names>G.</given-names></name><name><surname>Arnold</surname><given-names>P.</given-names></name><name><surname>Burroughs</surname><given-names>E.</given-names></name><name><surname>Barr</surname><given-names>C.L.</given-names></name><name><surname>Richter</surname><given-names>M.A.</given-names></name><name><surname>Kennedy</surname><given-names>J.L</given-names></name></person-group><article-title>Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder</article-title><source>Am. J. Med. Genet. B. Neuropsychiatr. Genet</source><year>2005</year><volume>134</volume><fpage>25</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15685626</pub-id></citation></ref><ref id="R56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>E.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Koizumi</surname><given-names>H.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Itoh</surname><given-names>K.</given-names></name><name><surname>Mitsumori</surname><given-names>M.</given-names></name><name><surname>Ohgake</surname><given-names>S.</given-names></name><name><surname>Okamura</surname><given-names>N.</given-names></name><name><surname>Koike</surname><given-names>K.</given-names></name><name><surname>Matsuzawa</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Kumakiri</surname><given-names>C.</given-names></name><name><surname>Nakazato</surname><given-names>M.</given-names></name><name><surname>Komatsu</surname><given-names>N.</given-names></name><name><surname>Iyo</surname><given-names>M</given-names></name></person-group><article-title>No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder</article-title><source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source><year>2005</year><volume>29</volume><fpage>708</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15913870</pub-id></citation></ref><ref id="R57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maron</surname><given-names>E.</given-names></name><name><surname>Nikopensius</surname><given-names>T.</given-names></name><name><surname>Koks</surname><given-names>S.</given-names></name><name><surname>Altmae</surname><given-names>S.</given-names></name><name><surname>Heinaste</surname><given-names>E.</given-names></name><name><surname>Vabrit</surname><given-names>K.</given-names></name><name><surname>Tammekivi</surname><given-names>V.</given-names></name><name><surname>Hallast</surname><given-names>P.</given-names></name><name><surname>Koido</surname><given-names>K.</given-names></name><name><surname>Kurg</surname><given-names>A.</given-names></name><name><surname>Metspalu</surname><given-names>A.</given-names></name><name><surname>Vasar</surname><given-names>E.</given-names></name><name><surname>Vasar</surname><given-names>V.</given-names></name><name><surname>Shlik</surname><given-names>J</given-names></name></person-group><article-title>Association study of 90 candidate gene polymorphisms in panic disorder</article-title><source>Psychiatr. Genet</source><year>2005</year><volume>15</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15722953</pub-id></citation></ref><ref id="R58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Hohoff</surname><given-names>C.</given-names></name><name><surname>Domschke</surname><given-names>K.</given-names></name><name><surname>Sand</surname><given-names>P.</given-names></name><name><surname>Kuhlenbaumer</surname><given-names>G.</given-names></name><name><surname>Schirmacher</surname><given-names>A.</given-names></name><name><surname>Freitag</surname><given-names>C.M.</given-names></name><name><surname>Meyer</surname><given-names>J.</given-names></name><name><surname>Stober</surname><given-names>G.</given-names></name><name><surname>Franke</surname><given-names>P.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Fritze</surname><given-names>J.</given-names></name><name><surname>Fimmers</surname><given-names>R.</given-names></name><name><surname>Garritsen</surname><given-names>H.S.</given-names></name><name><surname>Stogbauer</surname><given-names>F.</given-names></name><name><surname>Deckert</surname><given-names>J</given-names></name></person-group><article-title>Norepinephrine transporter (NET) promoter and 5'-UTR polymorphisms association: analysis in panic disorder</article-title><source>Neurosci. Lett</source><year>2005</year><volume>377</volume><fpage>40</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">15722184</pub-id></citation></ref><ref id="R59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maron</surname><given-names>E.</given-names></name><name><surname>Lang</surname><given-names>A.</given-names></name><name><surname>Tasa</surname><given-names>G.</given-names></name><name><surname>Liivlaid</surname><given-names>L.</given-names></name><name><surname>Toru</surname><given-names>I.</given-names></name><name><surname>Must</surname><given-names>A.</given-names></name><name><surname>Vasar</surname><given-names>V.</given-names></name><name><surname>Shlik</surname><given-names>J</given-names></name></person-group><article-title>Associations between serotonin-related gene polymorphisms and panic disorder</article-title><source>Int. J. Neuropsychopharmacol</source><year>2005</year><volume>8</volume><fpage>261</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15670397</pub-id></citation></ref><ref id="R60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname><given-names>S.G.</given-names></name><name><surname>Knapp</surname><given-names>M.</given-names></name><name><surname>Sklar</surname><given-names>P.</given-names></name><name><surname>Eckstein</surname><given-names>G.N.</given-names></name><name><surname>Sewekow</surname><given-names>C.</given-names></name><name><surname>Borrmann-Hassenbach</surname><given-names>M.</given-names></name><name><surname>Albus</surname><given-names>M.</given-names></name><name><surname>Becker</surname><given-names>T.</given-names></name><name><surname>Hallmayer</surname><given-names>J.F.</given-names></name><name><surname>Lerer</surname><given-names>B.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Wildenauer</surname><given-names>D.B</given-names></name></person-group><article-title>Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia</article-title><source>Mol. Psychiatry</source><year>2006</year><volume>11</volume><fpage>837</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">16801950</pub-id></citation></ref><ref id="R61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>S.H.</given-names></name><name><surname>Joo</surname><given-names>E.J.</given-names></name><name><surname>Ahn</surname><given-names>Y.M.</given-names></name><name><surname>Lee</surname><given-names>K.Y.</given-names></name><name><surname>Kim</surname><given-names>Y.S</given-names></name></person-group><article-title>Investigation of genetic association between human Frizzled homolog 3 gene (FZD3) and schizophrenia: results in a Korean population and evidence from meta-analysis</article-title><source>Psychiatry Res</source><year>2006</year><volume>143</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16707163</pub-id></citation></ref><ref id="R62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neves-Pereira</surname><given-names>M.</given-names></name><name><surname>Cheung</surname><given-names>J.K.</given-names></name><name><surname>Pasdar</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Breen</surname><given-names>G.</given-names></name><name><surname>Yates</surname><given-names>P.</given-names></name><name><surname>Sinclair</surname><given-names>M.</given-names></name><name><surname>Crombie</surname><given-names>C.</given-names></name><name><surname>Walker</surname><given-names>N.</given-names></name><name><surname>St Clair</surname><given-names>D.M</given-names></name></person-group><article-title>BDNF gene is a risk factor for schizophrenia in a Scottish population</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>208</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15630410</pub-id></citation></ref><ref id="R63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lachman</surname><given-names>H.M.</given-names></name><name><surname>Stopkova</surname><given-names>P.</given-names></name><name><surname>Papolos</surname><given-names>D.F.</given-names></name><name><surname>Pedrosa</surname><given-names>E.</given-names></name><name><surname>Margolis</surname><given-names>B.</given-names></name><name><surname>Aghalar</surname><given-names>M.R.</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><article-title>Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder</article-title><source>Neuropsychobiology</source><year>2006</year><volume>53</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16511335</pub-id></citation></ref><ref id="R64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro</surname><given-names>Q.</given-names></name><name><surname>Talkowski</surname><given-names>M.E.</given-names></name><name><surname>Chowdari</surname><given-names>K.V.</given-names></name><name><surname>Wood</surname><given-names>J.</given-names></name><name><surname>Nimgaonkar</surname><given-names>V.</given-names></name><name><surname>Vallada</surname><given-names>H</given-names></name></person-group><article-title>Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil</article-title><source>Genes Brain Behav</source><year>2005</year><volume>4</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15660667</pub-id></citation></ref><ref id="R65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selch</surname><given-names>S.</given-names></name><name><surname>Strobel</surname><given-names>A.</given-names></name><name><surname>Haderlein</surname><given-names>J.</given-names></name><name><surname>Meyer</surname><given-names>J.</given-names></name><name><surname>Jacob</surname><given-names>C.P.</given-names></name><name><surname>Schmitt</surname><given-names>A.</given-names></name><name><surname>Lesch</surname><given-names>K.P.</given-names></name><name><surname>Reif</surname><given-names>A</given-names></name></person-group><article-title>MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia</article-title><source>Biol. Psychiatry</source><year>2007</year><volume>61</volume><fpage>1211</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">17210142</pub-id></citation></ref><ref id="R66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chavarria-Siles</surname><given-names>I.</given-names></name><name><surname>Walss-Bass</surname><given-names>C.</given-names></name><name><surname>Quezada</surname><given-names>P.</given-names></name><name><surname>Dassori</surname><given-names>A.</given-names></name><name><surname>Contreras</surname><given-names>S.</given-names></name><name><surname>Medina</surname><given-names>R.</given-names></name><name><surname>Ramirez</surname><given-names>M.</given-names></name><name><surname>Armas</surname><given-names>R.</given-names></name><name><surname>Salazar</surname><given-names>R.</given-names></name><name><surname>Leach</surname><given-names>R.J.</given-names></name><name><surname>Raventos</surname><given-names>H.</given-names></name><name><surname>Escamilla</surname><given-names>M.A</given-names></name></person-group><article-title>TGFB-induced factor (TGIF): a candidate gene for psychosis on chromosome 18p</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>1033</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">17440433</pub-id></citation></ref><ref id="R67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pivac</surname><given-names>N.</given-names></name><name><surname>Knezevic</surname><given-names>J.</given-names></name><name><surname>Kozaric-Kovacic</surname><given-names>D.</given-names></name><name><surname>Dezeljin</surname><given-names>M.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Rak</surname><given-names>D.</given-names></name><name><surname>Matijevic</surname><given-names>T.</given-names></name><name><surname>Pavelic</surname><given-names>J.</given-names></name><name><surname>Muck-Seler</surname><given-names>D</given-names></name></person-group><article-title>Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder</article-title><source>J. Affect. Disord</source><year>2007</year><volume>103</volume><fpage>131</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17289152</pub-id></citation></ref><ref id="R68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabunciyan</surname><given-names>S.</given-names></name><name><surname>Yolken</surname><given-names>R.</given-names></name><name><surname>Ragan</surname><given-names>C.M.</given-names></name><name><surname>Potash</surname><given-names>J.B.</given-names></name><name><surname>Nimgaonkar</surname><given-names>V.L.</given-names></name><name><surname>Dickerson</surname><given-names>F.</given-names></name><name><surname>Llenos</surname><given-names>I.C.</given-names></name><name><surname>Weis</surname><given-names>S</given-names></name></person-group><article-title>Polymorphisms in the homeobox gene OTX2 may be a risk factor for bipolar disorder</article-title><source>Am. J. Med. Genet. B. Neuropsychiatr. Genet</source><year>2007</year><volume>144</volume><fpage>1083</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17541950</pub-id></citation></ref><ref id="R69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>K.W.</given-names></name><name><surname>Damberg</surname><given-names>M.</given-names></name><name><surname>Ohrvik</surname><given-names>J.</given-names></name><name><surname>Leppert</surname><given-names>J.</given-names></name><name><surname>Lindstrom</surname><given-names>L.</given-names></name><name><surname>Anckarsater</surname><given-names>H.</given-names></name><name><surname>Oreland</surname><given-names>L</given-names></name></person-group><article-title>Genes encoding for AP-2beta and the Serotonin Transporter are associated with the Personality Character Spiritual Acceptance</article-title><source>Neurosci. Lett</source><year>2007</year><volume>411</volume><fpage>233</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17123722</pub-id></citation></ref><ref id="R70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liou</surname><given-names>Y.J.</given-names></name><name><surname>Lai</surname><given-names>I.C.</given-names></name><name><surname>Lin</surname><given-names>M.W.</given-names></name><name><surname>Bai</surname><given-names>Y.M.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Liao</surname><given-names>D.L.</given-names></name><name><surname>Chen</surname><given-names>J.Y.</given-names></name><name><surname>Lin</surname><given-names>C.Y.</given-names></name><name><surname>Wang</surname><given-names>Y.C</given-names></name></person-group><article-title>Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia</article-title><source>Pharmacogenet. Genomics</source><year>2006</year><volume>16</volume><fpage>151</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16495774</pub-id></citation></ref><ref id="R71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>J.</given-names></name><name><surname>Scott</surname><given-names>A.C.</given-names></name><name><surname>Howard</surname><given-names>M.R.</given-names></name><name><surname>Breen</surname><given-names>G.</given-names></name><name><surname>Bubb</surname><given-names>V.J.</given-names></name><name><surname>Klenova</surname><given-names>E.</given-names></name><name><surname>Quinn</surname><given-names>J.P</given-names></name></person-group><article-title>Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat</article-title><source>J. Neurosci</source><year>2007</year><volume>27</volume><fpage>2793</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">17360901</pub-id></citation></ref><ref id="R72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Gara</surname><given-names>C.</given-names></name><name><surname>Stapleton</surname><given-names>J.</given-names></name><name><surname>Sutherland</surname><given-names>G.</given-names></name><name><surname>Guindalini</surname><given-names>C.</given-names></name><name><surname>Neale</surname><given-names>B.</given-names></name><name><surname>Breen</surname><given-names>G.</given-names></name><name><surname>Ball</surname><given-names>D</given-names></name></person-group><article-title>Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment</article-title><source>Pharmacogenet Genomics</source><year>2007</year><volume>17</volume><fpage>61</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17264803</pub-id></citation></ref><ref id="R73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tadic</surname><given-names>A.</given-names></name><name><surname>Rujescu</surname><given-names>D.</given-names></name><name><surname>Muller</surname><given-names>M.J.</given-names></name><name><surname>Kohnen</surname><given-names>R.</given-names></name><name><surname>Stassen</surname><given-names>H.H.</given-names></name><name><surname>Dahmen</surname><given-names>N.</given-names></name><name><surname>Szegedi</surname><given-names>A</given-names></name></person-group><article-title>A monoamine oxidase B gene variant and short-term antidepressant treatment response</article-title><source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source><year>2007</year><volume>31</volume><fpage>1370</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17640790</pub-id></citation></ref><ref id="R74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ando</surname><given-names>T.</given-names></name><name><surname>Ichimaru</surname><given-names>Y.</given-names></name><name><surname>Konjiki</surname><given-names>F.</given-names></name><name><surname>Shoji</surname><given-names>M.</given-names></name><name><surname>Komaki</surname><given-names>G</given-names></name></person-group><article-title>Variations in the preproghrelin gene correlate with higher body mass index, fat mass, and body dissatisfaction in young Japanese women</article-title><source>Am. J. Clin. Nutr</source><year>2007</year><volume>86</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17616759</pub-id></citation></ref><ref id="R75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schlaepfer</surname><given-names>I.R.</given-names></name><name><surname>Clegg</surname><given-names>H.V.</given-names></name><name><surname>Corley</surname><given-names>R.P.</given-names></name><name><surname>Crowley</surname><given-names>T.J.</given-names></name><name><surname>Hewitt</surname><given-names>J.K.</given-names></name><name><surname>Hopfer</surname><given-names>C.J.</given-names></name><name><surname>Krauter</surname><given-names>K.</given-names></name><name><surname>Lessem</surname><given-names>J.</given-names></name><name><surname>Rhee</surname><given-names>S.H.</given-names></name><name><surname>Stallings</surname><given-names>M.C.</given-names></name><name><surname>Wehner</surname><given-names>J.M.</given-names></name><name><surname>Young</surname><given-names>S.E.</given-names></name><name><surname>Ehringer</surname><given-names>M.A</given-names></name></person-group><article-title>The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition</article-title><source>Addict. Biol</source><year>2007</year><volume>12</volume><fpage>200</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17508994</pub-id></citation></ref><ref id="R76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borroni</surname><given-names>B.</given-names></name><name><surname>Grassi</surname><given-names>M.</given-names></name><name><surname>Costanzi</surname><given-names>C.</given-names></name><name><surname>Zanetti</surname><given-names>M.</given-names></name><name><surname>Archetti</surname><given-names>S.</given-names></name><name><surname>Franzoni</surname><given-names>S.</given-names></name><name><surname>Caimi</surname><given-names>L.</given-names></name><name><surname>Padovani</surname><given-names>A</given-names></name></person-group><article-title>Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease</article-title><source>Neurobiol. Aging</source><year>2007</year><volume>28</volume><fpage>1231</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16837108</pub-id></citation></ref><ref id="R77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dannlowski</surname><given-names>U.</given-names></name><name><surname>Ohrmann</surname><given-names>P.</given-names></name><name><surname>Bauer</surname><given-names>J.</given-names></name><name><surname>Kugel</surname><given-names>H.</given-names></name><name><surname>Baune</surname><given-names>B.T.</given-names></name><name><surname>Hohoff</surname><given-names>C.</given-names></name><name><surname>Kersting</surname><given-names>A.</given-names></name><name><surname>Arolt</surname><given-names>V.</given-names></name><name><surname>Heindel</surname><given-names>W.</given-names></name><name><surname>Deckert</surname><given-names>J.</given-names></name><name><surname>Suslow</surname><given-names>T</given-names></name></person-group><article-title>Serotonergic genes modulate amygdala activity in major depression</article-title><source>Genes Brain Behav</source><year>2006</year></citation></ref><ref id="R78"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gawlik</surname><given-names>M.</given-names></name><name><surname>Moller-Ehrlich</surname><given-names>K.</given-names></name><name><surname>Mende</surname><given-names>M.</given-names></name><name><surname>Jovnerovski</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><name><surname>Jabs</surname><given-names>B.</given-names></name><name><surname>Knapp</surname><given-names>M.</given-names></name><name><surname>Stoeber</surname><given-names>G</given-names></name></person-group><article-title>Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits</article-title><source>BMC Psychiatry</source><year>2006</year><volume>6</volume><fpage>52</fpage><pub-id pub-id-type="pmid">17081296</pub-id></citation></ref><ref id="R79"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>A.K.</given-names></name><name><surname>Deshpande</surname><given-names>S.N.</given-names></name><name><surname>Lerer</surname><given-names>B.</given-names></name><name><surname>Nimgaonkar</surname><given-names>V.L.</given-names></name><name><surname>Thelma</surname><given-names>B.K</given-names></name></person-group><article-title>Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C&#x0003e;T polymorphism</article-title><source>Pharmacogenomics J</source><year>2006</year></citation></ref><ref id="R80"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lohoff</surname><given-names>F.W.</given-names></name><name><surname>Dahl</surname><given-names>J.P.</given-names></name><name><surname>Ferraro</surname><given-names>T.N.</given-names></name><name><surname>Arnold</surname><given-names>S.E.</given-names></name><name><surname>Gallinat</surname><given-names>J.</given-names></name><name><surname>Sander</surname><given-names>T.</given-names></name><name><surname>Berrettini</surname><given-names>W.H</given-names></name></person-group><article-title>Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder</article-title><source>Neuropsychopharmacology</source><year>2006</year><volume>31</volume><fpage>2739</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">16936705</pub-id></citation></ref><ref id="R81"><label>81</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lachman</surname><given-names>H.M.</given-names></name><name><surname>Pedrosa</surname><given-names>E.</given-names></name><name><surname>Nolan</surname><given-names>K.A.</given-names></name><name><surname>Glass</surname><given-names>M.</given-names></name><name><surname>Ye</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><article-title>Analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia</article-title><source>Am. J. Med. Genet. B. Neuropsychiatr. Genet</source><year>2006</year><volume>141</volume><fpage>102</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16287046</pub-id></citation></ref><ref id="R82"><label>82</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Macciardi</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>P.P.</given-names></name><name><surname>Yoon</surname><given-names>I.S.</given-names></name><name><surname>Cooke</surname><given-names>R.G.</given-names></name><name><surname>Hughes</surname><given-names>B.</given-names></name><name><surname>Parikh</surname><given-names>S.V.</given-names></name><name><surname>McIntyre</surname><given-names>R.S.</given-names></name><name><surname>Kennedy</surname><given-names>J.L.</given-names></name><name><surname>Warsh</surname><given-names>J.J</given-names></name></person-group><article-title>Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder</article-title><source>Am. J. Med. Genet. B. Neuropsychiatr. Genet</source><year>2006</year><volume>141</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">16252251</pub-id></citation></ref><ref id="R83"><label>83</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaboli</surname><given-names>G.</given-names></name><name><surname>Gizatullin</surname><given-names>R.</given-names></name><name><surname>Nilsonne</surname><given-names>A.</given-names></name><name><surname>Wilczek</surname><given-names>A.</given-names></name><name><surname>Jonsson</surname><given-names>E.G.</given-names></name><name><surname>Ahnemark</surname><given-names>E.</given-names></name><name><surname>Asberg</surname><given-names>M.</given-names></name><name><surname>Leopardi</surname><given-names>R</given-names></name></person-group><article-title>Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women</article-title><source>Neuropsychopharmacology</source><year>2006</year><volume>31</volume><fpage>1982</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">16495936</pub-id></citation></ref><ref id="R84"><label>84</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viana</surname><given-names>M.M.</given-names></name><name><surname>De Marco</surname><given-names>L.A.</given-names></name><name><surname>Boson</surname><given-names>W.L.</given-names></name><name><surname>Romano-Silva</surname><given-names>M.A.</given-names></name><name><surname>Correa</surname><given-names>H</given-names></name></person-group><article-title>Investigation of A218C tryptophan hydroxylase polymorphism: association with familial suicide behavior and proband's suicide attempt characteristics</article-title><source>Genes Brain Behav</source><year>2006</year><volume>5</volume><fpage>340</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16716203</pub-id></citation></ref><ref id="R85"><label>85</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Hattori</surname><given-names>E.</given-names></name><name><surname>Iwayama</surname><given-names>Y.</given-names></name><name><surname>Ohnishi</surname><given-names>T.</given-names></name><name><surname>Ohba</surname><given-names>H.</given-names></name><name><surname>Toyota</surname><given-names>T.</given-names></name><name><surname>Takao</surname><given-names>H.</given-names></name><name><surname>Minabe</surname><given-names>Y.</given-names></name><name><surname>Nakatani</surname><given-names>N.</given-names></name><name><surname>Higuchi</surname><given-names>T.</given-names></name><name><surname>Detera-Wadleigh</surname><given-names>S.D.</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title>Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression</article-title><source>Biol. Psychiatry</source><year>2006</year><volume>60</volume><fpage>192</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">16487942</pub-id></citation></ref></ref-list></back><floats-wrap><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Examples of Investigated/Known Variations Ratio</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">Author</th><th rowspan="1" colspan="1">Sample</th><th rowspan="1" colspan="1">Gene (s)</th><th rowspan="1" colspan="1">Variation (Investigated / Known)</th><th rowspan="1" colspan="1">Number of Tag SNPs</th><th rowspan="1" colspan="1">Number of LD Blocks</th><th rowspan="1" colspan="1">Main Association Result</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R32">32</xref>] </td><td align="center" rowspan="1" colspan="1">1447 </td><td align="center" rowspan="1" colspan="1">CREB 1 </td><td align="center" rowspan="1" colspan="1">7 / 173 </td><td align="center" rowspan="1" colspan="1">18 </td><td align="center" rowspan="1" colspan="1">4 </td><td align="center" rowspan="1" colspan="1">Positive association in men (suicide) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R33">33</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">854</td><td align="center" valign="middle" rowspan="1" colspan="1">HTR2C; HTR1A</td><td align="center" rowspan="1" colspan="1">6 / 1100 (HTR2C); 3 / 16 (HTR1A)</td><td align="center" rowspan="1" colspan="1">18 (HTR2C) No haplotypes (HTR1A)</td><td align="center" rowspan="1" colspan="1">4 (HTR2C) No haplotypes (HTR1A)</td><td align="center" valign="middle" rowspan="1" colspan="1">No correlation </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R34">34</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">1913 </td><td align="center" valign="middle" rowspan="1" colspan="1">SLC6A4 </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">No correlation (MDD, positive correlation if stress associated; alcohol dependence)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R35">35</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">1435 (meta analysis)</td><td align="center" valign="middle" rowspan="1" colspan="1">SLC6A4 </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (MDD, AD treatment) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R36">36</xref>] </td><td align="center" rowspan="1" colspan="1">1914 </td><td align="center" rowspan="1" colspan="1">SLC6A4 </td><td align="center" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">No correlation (AD treatment) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R37">37</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">1648 (meta analysis)</td><td align="center" valign="middle" rowspan="1" colspan="1">MTHFR </td><td align="center" valign="middle" rowspan="1" colspan="1">2 / 147 </td><td align="center" rowspan="1" colspan="1">9 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (depression, anxiety, psychosis) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R38">38</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">9032 (meta analysis)</td><td align="center" valign="middle" rowspan="1" colspan="1">SLC6A4 </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (sucide; p = 0.0068) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R39">39</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">3000 (meta analysis)</td><td align="center" valign="middle" rowspan="1" colspan="1">SLC6A4 </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (OCD) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R40">40</xref>] </td><td align="center" rowspan="1" colspan="1">195 </td><td align="center" rowspan="1" colspan="1">GNbeta3 </td><td align="center" rowspan="1" colspan="1">1 / 39 </td><td align="center" rowspan="1" colspan="1">3 </td><td align="center" rowspan="1" colspan="1">No haplotypes </td><td align="center" rowspan="1" colspan="1">Positive correlation (self mutilation) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R41">41</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">222 </td><td align="center" valign="middle" rowspan="1" colspan="1">HTR1A </td><td align="center" valign="middle" rowspan="1" colspan="1">2 / 16 </td><td align="center" rowspan="1" colspan="1">No haplotypes </td><td align="center" rowspan="1" colspan="1">No haplotypes </td><td align="center" rowspan="1" colspan="1">Positive correlation (AD treatment, females) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R42">42</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">4175 (298 MDD)</td><td align="center" valign="middle" rowspan="1" colspan="1">SLC6A4 </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" valign="middle" rowspan="1" colspan="1">No correlation </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R43">43</xref>] </td><td align="center" rowspan="1" colspan="1">258 </td><td align="center" rowspan="1" colspan="1">SLC6A4 </td><td align="center" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (suicide) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R44">44</xref>] </td><td align="center" rowspan="1" colspan="1">196 </td><td align="center" rowspan="1" colspan="1">DRD4 </td><td align="center" rowspan="1" colspan="1">1 / 106 </td><td align="center" rowspan="1" colspan="1">No haplotypes </td><td align="center" rowspan="1" colspan="1">No haplotypes </td><td align="center" rowspan="1" colspan="1">Positive correlation (neuroticism) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R45">45</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">450 </td><td align="center" valign="middle" rowspan="1" colspan="1">GLO1 </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 152 </td><td align="center" rowspan="1" colspan="1">11 </td><td align="center" rowspan="1" colspan="1">2 </td><td align="center" rowspan="1" colspan="1">Positive correlation (panic without agoraphobia) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R46">46</xref>] </td><td align="center" rowspan="1" colspan="1">937 </td><td align="center" rowspan="1" colspan="1">GAL </td><td align="center" rowspan="1" colspan="1">4 / 30 </td><td align="center" rowspan="1" colspan="1">3 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (alcoholism) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R47">47</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">755 </td><td align="center" valign="middle" rowspan="1" colspan="1">DTNBP1 </td><td align="center" valign="middle" rowspan="1" colspan="1">2 / 448 </td><td align="center" rowspan="1" colspan="1">26 </td><td align="center" rowspan="1" colspan="1">2 </td><td align="center" rowspan="1" colspan="1">Positive correlation (negative symptoms of schizophrenia) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R48">48</xref>] </td><td align="center" rowspan="1" colspan="1">2376 </td><td align="center" rowspan="1" colspan="1">BDNF </td><td align="center" rowspan="1" colspan="1">3 / 214 </td><td align="center" rowspan="1" colspan="1">5 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (MDD) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R49">49</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">178 </td><td align="center" valign="middle" rowspan="1" colspan="1">CLOCK </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 523 </td><td align="center" rowspan="1" colspan="1">24 </td><td align="center" rowspan="1" colspan="1">5 </td><td align="center" rowspan="1" colspan="1">Positive correlation (AD treatment insomnia)		</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R50">50</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">273 </td><td align="center" valign="middle" rowspan="1" colspan="1">ACE; ATR1 </td><td align="center" valign="middle" rowspan="1" colspan="1">(1 + 1) / (259 + 422 )</td><td align="center" rowspan="1" colspan="1">11 (ACE) <break/> 18 (ATR1)</td><td align="center" rowspan="1" colspan="1">4 (ACE) <break/> 2 (ATR1)</td><td align="center" rowspan="1" colspan="1">Positive correlation (AD treatment)</td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R51">51</xref>] </td><td align="center" rowspan="1" colspan="1">1512 </td><td align="center" rowspan="1" colspan="1">COMT </td><td align="center" rowspan="1" colspan="1">1 / 293 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">3 </td><td align="center" rowspan="1" colspan="1">Positive correlation (MDD) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R52">52</xref>] </td><td align="center" rowspan="1" colspan="1">753 </td><td align="center" rowspan="1" colspan="1">GPR50 </td><td align="center" rowspan="1" colspan="1">3 / 29 </td><td align="center" rowspan="1" colspan="1">No haplotypes </td><td align="center" rowspan="1" colspan="1">No haplotypes </td><td align="center" rowspan="1" colspan="1">Positive correlation (DB) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R53">53</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">1005 </td><td align="center" valign="middle" rowspan="1" colspan="1">SLC6A4 </td><td align="center" valign="middle" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive correlation (gene environment influence) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R54">54</xref>] </td><td align="center" rowspan="1" colspan="1">295 </td><td align="center" rowspan="1" colspan="1">SLC6A4 </td><td align="center" rowspan="1" colspan="1">1 / 171 </td><td align="center" rowspan="1" colspan="1">14 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">No correlation (OCD) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R55">55</xref>] </td><td align="center" rowspan="1" colspan="1">159 </td><td align="center" rowspan="1" colspan="1">GABBR1 </td><td align="center" rowspan="1" colspan="1">5 / 204 </td><td align="center" rowspan="1" colspan="1">21 </td><td align="center" rowspan="1" colspan="1">6 </td><td align="center" rowspan="1" colspan="1">Positive correlation (OCD) </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R56">56</xref>] </td><td align="center" rowspan="1" colspan="1">287 </td><td align="center" rowspan="1" colspan="1">BDNF </td><td align="center" rowspan="1" colspan="1">2 / 214 </td><td align="center" rowspan="1" colspan="1">5 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">No correlation </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R57">57</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">273</td><td align="center" valign="middle" rowspan="1" colspan="1">21 candidate genes</td><td align="center" valign="middle" rowspan="1" colspan="1">90 polymorphisms (average = 3.5) </td><td align="center" rowspan="1" colspan="1">Different genes</td><td align="center" rowspan="1" colspan="1">Different genes</td><td align="center" valign="middle" rowspan="1" colspan="1">Positive association (PD) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R58">58</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">230 </td><td align="center" valign="middle" rowspan="1" colspan="1">NET </td><td align="center" valign="middle" rowspan="1" colspan="1">3 / 263 </td><td align="center" rowspan="1" colspan="1">25 </td><td align="center" rowspan="1" colspan="1">4 </td><td align="center" rowspan="1" colspan="1">Positive correlation (PD without agoraphobia) </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R59">59</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">373 </td><td align="center" valign="middle" rowspan="1" colspan="1">SCL6A4;<break/> MAOA; TPH1;<break/> HTR1B </td><td align="center" valign="middle" rowspan="1" colspan="1">2 / 171 (SLC6A4);<break/> 1 / 165 (MAOA);<break/> 1 / 81 (TPH1);<break/> 1 / 25 (HTR1B) </td><td align="center" valign="middle" rowspan="1" colspan="1">14 (SLC6A4)<break/> 8 (MAOA)<break/> 2 (TPH1)<break/> 4 (HTR1B)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (SLC6A4)<break/> 1 (MAOA)<break/> None (TPH1)<break/> 1 (HTR1B)</td><td align="center" valign="middle" rowspan="1" colspan="1">No correlation </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R60">60</xref>] </td><td align="center" rowspan="1" colspan="1">65 families </td><td align="center" rowspan="1" colspan="1">PIP5K2A </td><td align="center" rowspan="1" colspan="1">15 / 742 </td><td align="center" rowspan="1" colspan="1">53 </td><td align="center" rowspan="1" colspan="1">12 </td><td align="center" rowspan="1" colspan="1">Positive association </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R61">61</xref>] </td><td align="center" rowspan="1" colspan="1">433 </td><td align="center" rowspan="1" colspan="1">FZD3 </td><td align="center" rowspan="1" colspan="1">2 / 280 </td><td align="center" rowspan="1" colspan="1">4 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">No correlation </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R62">62</xref>] </td><td align="center" rowspan="1" colspan="1">944 </td><td align="center" rowspan="1" colspan="1">BDNF </td><td align="center" rowspan="1" colspan="1">2 / 214 </td><td align="center" rowspan="1" colspan="1">5 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">Positive association </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R63">63</xref>] </td><td align="center" rowspan="1" colspan="1">896 </td><td align="center" rowspan="1" colspan="1">SYN3 </td><td align="center" rowspan="1" colspan="1">1 / 2742 </td><td align="center" rowspan="1" colspan="1">257 </td><td align="center" rowspan="1" colspan="1">45 </td><td align="center" rowspan="1" colspan="1">No correlation </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R64">64</xref>] </td><td align="center" rowspan="1" colspan="1">1153 </td><td align="center" rowspan="1" colspan="1">RGS4 </td><td align="center" rowspan="1" colspan="1">4 / 36 </td><td align="center" rowspan="1" colspan="1">6 </td><td align="center" rowspan="1" colspan="1">1 </td><td align="center" rowspan="1" colspan="1">No correlation </td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Gene names are the officials ones according to NCBI database. To identify the Tag SNPs Haploviewer tagger program was used with default settings, CEU population was selected.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Papers Published in 2006&#x02013;7 that Reported Positive Association Results for Intronic SNPs</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">Author</th><th rowspan="1" colspan="1">Disorder</th><th rowspan="1" colspan="1">Chromosome</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Variation (Intron)</th><th rowspan="1" colspan="1">Distance from the Nearest Exon</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R65">65</xref>] </td><td align="center" rowspan="1" colspan="1">Psychosis </td><td align="center" rowspan="1" colspan="1">22q13.33 </td><td align="center" rowspan="1" colspan="1">MLC1 </td><td align="center" rowspan="1" colspan="1">rs2235349; rs2076137 </td><td align="center" rowspan="1" colspan="1">~ 100 bp and 65 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R66">66</xref>] </td><td align="center" rowspan="1" colspan="1">Psychosis </td><td align="center" rowspan="1" colspan="1">18p11.3 </td><td align="center" rowspan="1" colspan="1">TGIF </td><td align="center" rowspan="1" colspan="1">D18S63 </td><td align="center" rowspan="1" colspan="1">~ 9.2 kbp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R67">67</xref>] </td><td align="center" rowspan="1" colspan="1">PTSD </td><td align="center" rowspan="1" colspan="1">Xp11.23 </td><td align="center" rowspan="1" colspan="1">MAO-B </td><td align="center" rowspan="1" colspan="1">rs1799836 </td><td align="center" rowspan="1" colspan="1">~ 30 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R68">68</xref>] </td><td align="center" rowspan="1" colspan="1">BD </td><td align="center" rowspan="1" colspan="1">14q22.3 </td><td align="center" rowspan="1" colspan="1">OTX2 </td><td align="center" rowspan="1" colspan="1">rs28757218 </td><td align="center" rowspan="1" colspan="1">~ 20 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R69">69</xref>]</td><td align="center" rowspan="1" colspan="1">Personality </td><td align="center" rowspan="1" colspan="1">6p12.3 </td><td align="center" rowspan="1" colspan="1">TFAP2B </td><td align="center" rowspan="1" colspan="1">VNTR (intron 2) </td><td align="center" rowspan="1" colspan="1">~ 100 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R70">70</xref>] </td><td align="center" rowspan="1" colspan="1">Antipsychotic treatment</td><td align="center" rowspan="1" colspan="1">7q36.1 </td><td align="center" rowspan="1" colspan="1">NOS3 </td><td align="center" rowspan="1" colspan="1">VNTR (intron 4) </td><td align="center" rowspan="1" colspan="1">~ 200 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R71">71</xref>] </td><td align="center" rowspan="1" colspan="1">Lithium treatment response </td><td align="center" rowspan="1" colspan="1">17q11.2 </td><td align="center" rowspan="1" colspan="1">SLC6A4 </td><td align="center" rowspan="1" colspan="1">VNTR (intron2) </td><td align="center" rowspan="1" colspan="1">~ 100 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R72">72</xref>] </td><td align="center" rowspan="1" colspan="1">Antidepressant response</td><td align="center" rowspan="1" colspan="1">5p15.33 </td><td align="center" rowspan="1" colspan="1">DAT1 </td><td align="center" rowspan="1" colspan="1">VNTR (intron 8) </td><td align="center" rowspan="1" colspan="1">~ 200 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R73">73</xref>] </td><td align="center" rowspan="1" colspan="1">Antidepressant response</td><td align="center" rowspan="1" colspan="1">Xp11.23 </td><td align="center" rowspan="1" colspan="1">MAO-B </td><td align="center" rowspan="1" colspan="1">rs1799836 </td><td align="center" rowspan="1" colspan="1">~ 30 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R74">74</xref>] </td><td align="center" rowspan="1" colspan="1">Eating disorder spectrum </td><td align="center" rowspan="1" colspan="1">3p25.3 </td><td align="center" rowspan="1" colspan="1">GHRL </td><td align="center" rowspan="1" colspan="1">rs35680 </td><td align="center" rowspan="1" colspan="1">~ 800 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R75">75</xref>]</td><td align="center" rowspan="1" colspan="1">Personality </td><td align="center" rowspan="1" colspan="1">19q13.42 </td><td align="center" rowspan="1" colspan="1">PRKCG </td><td align="center" rowspan="1" colspan="1">rs402691 </td><td align="center" rowspan="1" colspan="1">1.2 kbp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R76">76</xref>] </td><td align="center" rowspan="1" colspan="1">Psychosis </td><td align="center" rowspan="1" colspan="1">22q11.21 </td><td align="center" rowspan="1" colspan="1">COMT </td><td align="center" rowspan="1" colspan="1">rs737865; rs737864 </td><td align="center" rowspan="1" colspan="1">~ 700 kb </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R77">77</xref>] </td><td align="center" rowspan="1" colspan="1">Depressive disorder </td><td align="center" rowspan="1" colspan="1">17q11.2 </td><td align="center" rowspan="1" colspan="1">SLC6A4 </td><td align="center" rowspan="1" colspan="1">rs25531 </td><td align="center" rowspan="1" colspan="1">~ 1.5 kbp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R78">78</xref>] </td><td align="center" rowspan="1" colspan="1">Psychosis </td><td align="center" rowspan="1" colspan="1">6p21.31 </td><td align="center" rowspan="1" colspan="1">FKBP5 </td><td align="center" rowspan="1" colspan="1">17081296 </td><td align="center" rowspan="1" colspan="1">~ 2.5 kbp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R79">79</xref>] </td><td align="center" rowspan="1" colspan="1">Antipsychotic response</td><td align="center" rowspan="1" colspan="1">15q24.1 </td><td align="center" rowspan="1" colspan="1">CYP1A2 </td><td align="center" rowspan="1" colspan="1">rs2472304 </td><td align="center" rowspan="1" colspan="1">~ 40 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R80">80</xref>] </td><td align="center" rowspan="1" colspan="1">BD </td><td align="center" rowspan="1" colspan="1">8p21 </td><td align="center" rowspan="1" colspan="1">VMAT1 </td><td align="center" rowspan="1" colspan="1">rs2279709 </td><td align="center" rowspan="1" colspan="1">~ 220 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R81">81</xref>] </td><td align="center" rowspan="1" colspan="1">Psychosis </td><td align="center" rowspan="1" colspan="1">8p12 </td><td align="center" rowspan="1" colspan="1">NRG1 </td><td align="center" rowspan="1" colspan="1">rs6150532 </td><td align="center" rowspan="1" colspan="1">~ 700 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R82">82</xref>] </td><td align="center" rowspan="1" colspan="1">BD </td><td align="center" rowspan="1" colspan="1">21q22.3 </td><td align="center" rowspan="1" colspan="1">TRPM2 </td><td align="center" rowspan="1" colspan="1">rs1618355 </td><td align="center" rowspan="1" colspan="1">~ 15 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R83">83</xref>] </td><td align="center" rowspan="1" colspan="1">Suicide </td><td align="center" rowspan="1" colspan="1">11p15.1 </td><td align="center" rowspan="1" colspan="1">TPH-1 </td><td align="center" rowspan="1" colspan="1">rs684302; rs211105; rs1800532; rs7933505 </td><td align="center" rowspan="1" colspan="1">~ 250 to 2000 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R78">78</xref>]</td><td align="center" rowspan="1" colspan="1">Psychosis </td><td align="center" rowspan="1" colspan="1">6p21.31 </td><td align="center" rowspan="1" colspan="1">FKBP5 </td><td align="center" rowspan="1" colspan="1">rs1360780 </td><td align="center" rowspan="1" colspan="1">~ 1.5 kbp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R44">44</xref>]</td><td align="center" rowspan="1" colspan="1">Personality </td><td align="center" rowspan="1" colspan="1">7p15.1 </td><td align="center" rowspan="1" colspan="1">CRHR2 </td><td align="center" rowspan="1" colspan="1">rs2267717 </td><td align="center" rowspan="1" colspan="1">~4.5 kbp</td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R84">84</xref>] </td><td align="center" rowspan="1" colspan="1">Suicide </td><td align="center" rowspan="1" colspan="1">11p15.1 </td><td align="center" rowspan="1" colspan="1">TPH </td><td align="center" rowspan="1" colspan="1">Intron 7 SNPs </td><td align="center" rowspan="1" colspan="1">&#x0003c; 750 bp </td></tr><tr><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R85">85</xref>] </td><td align="center" rowspan="1" colspan="1">Depressive disorder </td><td align="center" rowspan="1" colspan="1">11q23.2 </td><td align="center" rowspan="1" colspan="1">HTR3A and HTR3B</td><td align="center" rowspan="1" colspan="1">rs2276307; rs2276308; rs3782025; rs2276302 </td><td align="center" rowspan="1" colspan="1">From 60 to 150 bp </td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>Gene names are the officials ones according to NCBI database.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article>